American Association for Cancer Research appoints Salk scientists to inaugural class of fellows
The American Association for Cancer Research (AACR), the world's oldest and largest professional organization dedicated to accelerating scientific progress to prevent and cure cancer, selected four Salk scientists and two of the Institute's nonresident fellows to be inducted into its first class of fellows of the AACR Academy.
"Membership in the fellows of the AACR Academy will be the most prestigious honor bestowed by the American Association for Cancer Research," says Margaret Foti, chief executive officer of the AACR.
Distinguished professors and Nobel laureates Sydney Brenner and Roger Guillemin, and faculty members Tony Hunter, a professor in the Molecular and Cell Biology Laboratory and director of Salk Institute Cancer Center, and Geoffrey M. Wahl, a professor in the Gene Expression Laboratory, were honored at a special ceremony on April 5, at the National Museum of Women in the Arts in Washington, D.C.
Salk nonresident fellows and Nobel laureates David Baltimore and Elizabeth H. Blackburn were also named to the academy.
"It is a great honor to have a team of our scientists chosen for the inaugural class of the AACR fellows and is indicative of the deep commitment and impact of our research in fighting cancer," says Salk president William R. Brody.
The AACR Fellows Academy is a separate entity within the American Association for Cancer Research, and only individuals who have made exceptional contributions to cancer and/or cancer-related biomedical science are eligible for election. It was created to recognize and honor distinguished scientists whose major scientific contributions have propelled significant innovation and progress against cancer.
The inaugural class of fellows includes 106 individuals, to symbolize the age of the organization upon establishment of the academy. Future classes of fellows will consist of no more than 11 individuals, in honor of the founding members of the American Association for Cancer Research.